This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in


Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Proton pump inhibitors (PPIs) such as omeprazole and lansoprazole inhibit the production of gastric acid.

They are the drugs of choice for patients with significant erosive oesophagitis and for patients with Zollinger- Ellinson syndrome.

The NICE guideline concerning the management of dyspepsia in primary care suggests PPIs as first-line therapies in non-ulcer dyspepsia, gastro-oesophageal reflux disease and peptic ulcer disease (see linked NICE dyspepsia guideline).

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.